The menopause and lipid metabolism: strategies for cardiovascular disease prevention

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Menopause Research

Background:

• Menopause and its associated biological changes, particularly in cardiovascular systems, remain poorly understood.
• Estrogen's role in cardiovascular disease prevention involves managing risk factors and directly influencing vessel health.
• The impact of progestogens on these cardiovascular effects is still under investigation.

Purpose of the Study:

• To explore the biological and molecular changes in cardiovascular tissues post-menopause.
• To evaluate the efficacy and risks of hormone replacement therapy (HRT) in postmenopausal women.
• To compare HRT with alternative cardiovascular risk management strategies.

Main Methods:

• Review of experimental and clinical evidence on estrogen and progestogen effects.
• Analysis of health risks associated with hormone replacement therapy.
• Consideration of lipid-lowering therapy as an alternative intervention.

Main Results:

• Estrogens show potential in correcting cardiovascular risk factors and regulating vessel structure/function.
• Hormone replacement therapy presents a complex profile of reduced, raised, and uncertain health risks.
• Further clinical trials are necessary to clarify the full benefits and risks of HRT.

Conclusions:

• The precise biological mechanisms of menopause on cardiovascular health require further elucidation.
• Hormone replacement therapy's role in cardiovascular disease prevention is not fully established, necessitating cautious application.
• Lipid-lowering therapy emerges as a viable alternative for cardiovascular risk reduction in postmenopausal women.